Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATX | ALT | ORGO | ||
| Company | Perspective Therapeutics Inc | Altimmune Inc | Organogenesis Holdings Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 8.93 | 8.27 | 4.11 | ||
| High | 8.93 | 8.54 | 4.12 | ||
| Low | 7.87 | 7.45 | 3.77 | ||
| Last | 7.88 | 7.61 | 3.86 | ||
| Change | -1.04 | -0.84 | -0.15 | ||
| % Change | -11.66% | -9.99% | -3.62% | ||
| Volume | 1,849,300 | 5,412,700 | 687,100 | ||
| 20-Day Average Volume | 737,395 | 3,734,105 | 572,325 | ||
| Previous Close | 8.92 | 8.45 | 4.01 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.39 | 7.36 | 3.21 | ||
| 20-Day Raw Stochastic | 0.20% | 24.63% | 60.99% | ||
| 20-Day Relative Strength | 25.42% | 52.91% | 62.32% | ||
| Weighted Alpha | +19.88 | +43.07 | +50.06 | ||
| Today's Opinion | 100% Sell | 40% Buy | 100% Buy | ||
| Previous Opinion | 100% Sell | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Sell | 48% Sell | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -29.96% since 11/08/24 | -0.91% since 11/08/24 | +17.68% since 11/08/24 | ||
| Low | 7.87 on 11/15/24 | 6.92 on 11/11/24 | 3.33 on 11/11/24 | ||
| High | 11.69 on 11/11/24 | 11.16 on 11/13/24 | 4.57 on 11/13/24 | ||
| 1-Month | |||||
| %Chg | -37.26% since 10/15/24 | +8.10% since 10/15/24 | +20.62% since 10/15/24 | ||
| Low | 7.87 on 11/15/24 | 6.45 on 11/04/24 | 2.75 on 11/04/24 | ||
| High | 13.19 on 10/17/24 | 11.16 on 11/13/24 | 4.57 on 11/13/24 | ||
| 3-Month | |||||
| %Chg | -43.55% since 08/15/24 | +21.96% since 08/15/24 | +53.17% since 08/15/24 | ||
| Low | 7.87 on 11/15/24 | 5.86 on 10/01/24 | 2.45 on 08/16/24 | ||
| High | 16.55 on 08/26/24 | 11.16 on 11/13/24 | 4.57 on 11/13/24 | ||
| 6-Month | |||||
| %Chg | -49.81% since 05/15/24 | -14.21% since 05/15/24 | +29.97% since 05/15/24 | ||
| Low | 7.87 on 11/15/24 | 5.28 on 08/05/24 | 2.28 on 08/12/24 | ||
| High | 16.90 on 05/20/24 | 11.16 on 11/13/24 | 4.57 on 11/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 532,593 | 541,261 | 511,747 | ||
| Shares Outstanding, K | 67,588 | 71,125 | 132,577 | ||
| Annual Sales | 1,430,000 | 430,000 | 433,140,000 | ||
| Annual Net Income | -46,510,000 | -88,450,000 | 4,950,000 | ||
| Last Quarter Sales | 530,000 | 10,000 | 130,230,000 | ||
| Last Quarter Net Income | -11,700,000 | -24,640,000 | -17,040,000 | ||
| 60-Month Beta | 1.46 | 0.09 | 1.60 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 11/12/24 | -0.32 on 11/12/24 | 0.09 on 11/12/24 | ||
| Latest Earnings Date | 11/12/24 | 11/12/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | 2.910 on 02/06/17 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||